Direct effects of rosuvastatin on pancreatic human beta cells

Acta Diabetologica

Volumn 50, Issue 6, 2013, Pages 983-985

  Bugliani, Marco ^a   Syed, Farooq ^a   Masini, Matilde ^a   Marselli, Lorella ^a   Suleiman, Mara ^a   Novelli, Michela ^a   Filipponi, Franco ^a   Boggi, Ugo ^a   Masiello, Pellegrino ^a   De Tata, Vincenzo ^a   Marchetti, Piero ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; MANGANESE SUPEROXIDE DISMUTASE; PALMITIC ACID; ROSUVASTATIN;

ARTICLE; CELL COUNT; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN RELEASE; LIPOTOXICITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ULTRASTRUCTURE;

AGED; CELLS, CULTURED; FEMALE; FLUOROBENZENES; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PYRIMIDINES; SULFONAMIDES;

EID: 84890549094     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0465-y     Document Type: Article

References (12)

1. Gotto AM Jr, Moon JE (2012) Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol 110(1 Suppl):3A-14A
2. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, Halperin I, Vachon B, Ramsay T, Manns B, Tonelli M, Shojania K (2012) Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet 379:2252-2261
3. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195-2207
4. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375:735-742
5. Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ (2012) Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 380:565-571
6. Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S (2012) The controversies of statin therapy: weighing the evidence. J Am Coll Cardiol 60:875-881
7. Taskinen MR (2002) Controlling lipid levels in diabetes. Acta Diabetol 39(Suppl 2):S29-S34
8. Bugliani M, Liechti R, Cheon H, Suleiman M, Marselli L, Kirkpatrick C, Filipponi F, Boggi U, Xenarios I, Syed F, Ladiere L, Wollheim C, Lee MS, Marchetti P (2012) Microarray analysis of isolated human islet transcriptome in type 2 diabetes and the role of the ubiquitin-proteasome system in pancreatic beta cell dysfunction. Mol Cell Endocrinol. doi: 10.1016/j.mce.2012.12.001
9. Masini M, Bugliani M, Lupi R, del Guerra S, Boggi U, Filipponi F, Marselli L, Masiello P, Marchetti P (2009) Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 52:1083-1086
10. Gallo R, Natale M, Vendrame F, Boggi U, Filipponi F, Marchetti P, Laghi Pasini F, Dotta F (2012) In vitro effects of mycophenolic acid on survival, function, and gene expression of pancreatic beta-cells. Acta Diabetol 49(Suppl 1):123-131
11. Masini M, Marselli L, Bugliani M, Martino L, Masiello P, Marchetti P, De Tata V (2012) Ultrastructural morphometric analysis of insulin secretory granules in human type 2 diabetes. Acta Diabetol 49(Suppl 1):247-252
12. Navarese EP, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, Caputo S, Grzesk G, Kubica A, Swiatkiewicz I, Sukiennik A, Kelm M, De Servi S, Kubica J (2013) Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol. doi: 10.1016/j.amjcard.2012.12.037